The Increasing Importance of Manufacturability in API Development
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
Navigating the Future
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
AI in Pharmaceutical Manufacturing Operations
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
From Clinical Trials to Pharmacovigilance: A Multi-Agent Future
The industry has automated within silos not across them Your clinical data management systems dont communicate with safety databases Trial monitoring...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Forgotten Biology: The Missing Link Behind Trial Outcomes
Clinical trials are often described as the science of uncertainty and that uncertainty is expected It is how evidence is built However not all uncertainty is scientific In many cases it arises when the biological context of an intervention is not carried through into the study population
-
Techno Trends
Terns Pharmaceuticals Secures FDA Breakthrough Therapy Designation for TERN-701 in CML
Terns Pharmaceuticals Inc has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration for TERN a novel oral allosteric BCRABL inhibitor
-
Projects
PCI Pharma Services Expands Global Manufacturing Network with $1B+ Investment in San Diego
PCI Pharma Services has announced an investment programme exceeding billion across its US and European operations to strengthen sterile fillfinish and advanced drug delivery capabilities
-
Research Insights
Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer’s disease via data fusion and machine learning
Accurately predicting which individuals with mild cognitive impairment MCI will progress to Alzheimers disease AD can improve patient care This study examines the role of quantitative MRI qMRI cognitive evaluations
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Key Challenges in Drug Manufacturing and How to Overcome Them
Kate Williamson
Some of the issues intrinsic to drug manufacturing include the capability to maintain quality, regulatory requirements, cost, supply chain issues, expansion, information technology interface, and the...
-
2
Biotech Breakthroughs and Pharma Frontiers: Emerging Modalities in Cancer Treatment
Subathra Ramamoorthy
A revolution is underway in cancer treatment, driven by novel modalities that promise greater precision and efficacy. This article examines paradigm-shifting approaches such as CAR-T cell therapy, bis...
-
3
Navigating the Storm: Emerging Challenges in the Pharmaceutical Industry
Kate Williamson
The pharmaceutical industry faces significant challenges, including regulatory complexities, pricing pressures, supply chain disruptions, technological advancements, and antimicrobial resistance. Navi...
-
4
Reimagining the Future of Pharma: Emerging Trends and Transformative Technologies
Dr. Sakshi Rastogi
The pharmaceutical sector is fleetly evolving with AI-driven drug discovery, digital therapeutics, rectifiers, genomics to accelerate research and development. Emerging technologies- mRNA vaccines, we...
-
5
Why Are Nanotechnology Applications Important In Pharma Drug Delivery Systems?
Kate Williamson
Nanotechnology revolutionizes pharmaceutical drug delivery by addressing challenges in solubility, targeting, and sustained release. Engineered nanoparticles enhance drug efficacy, reduce side effects...
press releasesRead more...
Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)
Mabwell SH HK an innovationdriven biopharmaceutical company with a fully integrated industry chain announced that the supplemental application for MAIWEIJIAN Denosumab Injection RD code
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
Eton Pharmaceuticals Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced it has entered into a supply and distribution agreement
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
SERB Pharmaceuticals SERB and Hansa Biopharma AB Hansa Nasdaq Stockholm HNSA today announced that they have entered into an agreement under which SERB will acquire the exclusive development and commercialisation
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
Viatris Inc a global healthcare company today announced that the US Food and Drug Administration FDA has accepted for review the New Drug Application NDA for MRA fastacting meloxicam
Events Read more...
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
20 - 22
May 2026PHARMA EURASIA 2026
Pharma & Med Tech Park, Tashkent, Uzbekistan
20 - 21
May 2026Pharma Partnering EU Summit 2026
Basel Marriott Hotel, Switzerland
21 - 22
May 2026Liver Diseases & Hepatology 2026
Paris, France
27 - 28
May 2026Future Labs Live 2026
Congress Center, Basel, Switzerland
27 - 28
May 2026UK Biotech Day 2026
Radisson Hotel & Conference Centre London Heathrow, UK
27 - 28
May 2026Digi-Tech Pharma & AI Conference
London, United Kingdom
27 - 28
May 2026Global Clinical Trials Connect 2026
London, United Kingdom
LATEST NEWSRead more...
Collaborative Drug Discovery Partners with Lilly TuneLab to Integrate AI Models into CDD Vault
Collaborative Drug Discovery CDD a provider of data management solutions for the pharmaceutical and biotechnology sectors has entered into an agreement with Eli Lilly and Company to integrate Lilly TuneLab into CDD Vault
BioCareSD partners with WeInfuse to expand infusion technology capabilities
BioCareSD has entered into a partnership with WeInfuse to strengthen technology support for infusion practices and pharmacies across the United States
MEKanistic Therapeutics receives FDA clearance for MTX-531 cancer therapy trial
MEKanistic Therapeutics has received clearance from the US Food and Drug Administration for its Investigational New Drug IND application for MTX allowing the company to begin a Phase clinical trial in advanced solid tumours
Bio-Thera Solutions’ Golimumab Biosimilars Receive FDA Approval in the US
BioThera Solutions and Accord BioPharma have announced that the US Food and Drug Administration FDA has approved IMMGOLIS golimumabsldi and IMMGOLIS INTRI golimumabsldi the first biosimilars to Simponi and Simponi Aria in the United States
Dr. Reddy’s launches generic Semaglutide injection in Canada
Dr Reddys Laboratories has launched its generic Semaglutide Injection in Canada after receiving approval from Health Canada on April The company is among the first to introduce a generic version
Lilly and UNICEF collaborate to support children’s health in low- and middle-income countries
Eli Lilly and Company and UNICEF USA have announced a new collaboration to improve prevention and care for noncommunicable diseases NCDs among children and adolescents in low and middleincome countries
